Cruinn Diagnostics Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cruinn Diagnostics Limited - overview
Established
1998
Location
Dublin, -, Ireland
Primary Industry
Medical Devices & Equipment
About
Cruinn Diagnostics Limited is a clinical diagnostics company specializing in laboratory equipment and services for life sciences and pharmaceuticals, enhancing diagnostic capabilities in healthcare and research sectors. Cruinn Diagnostics Limited, established in 1998 in Dublin, Ireland, focuses on providing innovative clinical diagnostics solutions. The company has undergone strategic pivots to strengthen its market presence and cater to evolving healthcare needs. Cruinn Diagnostics specializes in clinical diagnostics laboratory equipment and furniture, primarily serving life sciences and pharmaceutical markets.
Their product range includes pre-analytics solutions, near-patient testing tools, ultrasound equipment, and tailored services for healthcare providers and research institutions. The company caters to a diverse clientele, including hospitals and diagnostic laboratories, with its products designed to improve diagnostic accuracy and workflow efficiency. In 2022, Cruinn Diagnostics reported revenue of EUR 85,088,199. 40 and an EBITDA of EUR 14,626,145.
90, underscoring the financial health of the company through its transactional sales model, which includes direct sales and service contracts with healthcare institutions and research organizations. Cruinn Diagnostics plans to utilize the recent EUR 12 million funding from MML Growth Capital Partners Ireland to support its organic expansion into new diagnostic areas and potential acquisitions. The company aims to introduce new products and expand into targeted markets across Europe and beyond. In August 2025, Waterland Private Equity Investments agreed to acquire a 52% majority stake in Cruinn Diagnostics Limited from MML Capital Ireland.
Financial terms of the transaction were not disclosed. As part of the transaction, the company's management reinvested in the business.
Current Investors
MML Capital Ireland
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Medical Supplies, Diagnostic Equipment
Website
www.cruinn.ie
Verticals
E-commerce, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Cruinn Diagnostics Limited - timeline of key events
Cruinn Diagnostics Limited - financials
| Fiscal Year Ended | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 14,730,926 | 14,777,710 | 14,598,525 | - | - | - | 18,643,034 | 20,663,919 | 32,313,995 | 67,783,111 | - | - | - |
| % Revenue Growth (YoY) | - | 0.3% | (1.2%) | - | - | - | - | 10.8% | 56.4% | 109.8% | - | - | - |
| EBITDA (USD) | 1,283,663 | 929,060 | 699,243 | 774,108 | 741,913 | 1,126,370 | 1,367,413 | 1,611,458 | 792,808 | 11,707,647 | - | - | - |
| Operating Income (USD) | 535,933 | 181,764 | 10,914 | 163,309 | 130,608 | 590,334 | 726,492 | 930,959 | (30,642) | 10,925,060 | - | - | - |
| Operating Margin | 3.6% | 1.2% | 0.1% | - | - | - | 3.9% | 4.5% | (0.1%) | 16.1% | - | - | - |
| % EBITDA Margin | 8.7% | 6.3% | 4.8% | - | - | - | 7.3% | 7.8% | 2.5% | 17.3% | - | - | - |
| NET Income (USD) | 396,943 | 118,470 | (16,036) | 116,206 | 46,759 | 141,850 | 595,048 | 726,849 | 3,213,434 | 9,471,883 | - | - | - |
| % Net Margin | 2.7% | 0.8% | (0.1%) | - | - | - | 3.2% | 3.5% | 9.9% | 14.0% | - | - | - |
Cruinn Diagnostics Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Cruinn Diagnostics Limited | - | ||||||||
| Buyout | Completed | Cruinn Diagnostics Limited | - |
Displaying 1 - 2 of 2
Cruinn Diagnostics Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.